Autoimmune Disease Research Study
This clinical research study is investigating the safety, tolerability and effects of an investigational treatment that aims to reduce disease activity in people living with autoimmune diseases. The treatment is given by intravenous (IV) infusion and is being studied to determine whether it may provide another treatment option in the future.
Study overview
Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and systemic sclerosis (SSc) occur when the immune system mistakenly attacks healthy tissues. These conditions can cause ongoing inflammation, pain, fatigue and other symptoms that may affect everyday life. While current treatments help many people, they do not work for everyone, and some people continue to experience active disease despite treatment.
Am I eligible?
You may be eligible if:
- Are aged 18–65 years old
- Have been diagnosed with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) or systemic sclerosis (SSc)
- You have a caregiver or family member who can stay with you for 24 hours after each of the first two infusion visits
- You have not received cancer treatment in the last 3 years
What taking part involves
If this study is suitable for you and if you agree to participate, you will take part in the study for about 13 months, which includes screening, treatment, and follow-up. The screening period lasts up to 35 days and takes up to 6 hours. Treatment will be given on two infusion visits (dosing visits) on Day 1 and Day 8, each lasting about 10 hours. Between these, there are several shorter check-in visits on Days 2, 4, 9, 11, and 14, each lasting about an hour. On Day 29, participants return for a longer visit of about 3 hours, which includes planned assessments. After this, follow-up visits continue monthly for the first 6 months, and then every 3 months until Month 12. In total, there are around 16 clinic visits.
During the study, participants will receive the investigational treatment by intravenous (IV) infusion into a vein in the arm during the two treatment visits. Throughout the study, participants will complete a range of health assessments, which may include medical history, physical examinations, vital signs, ECGs, chest imaging, blood and urine tests, and health questionnaires.
Depending on your medical history and condition, you may also be required to undergo additional assessments, such as a kidney biopsy, skin photography, lung function tests, heart assessments or other study-related procedures. After each treatment visit, a caregiver, friend or family member will need to stay with the participant for 24 hours to help monitor their wellbeing.
- 1
Enquiry & phone call
We call to explain the study and answer your questions.
- 2
Screening visit
Meet the team and have health checks to confirm eligibility.
- 3
Study visits
Regular visits with expert care and health monitoring.
- 4
Final visit & follow-up
A wrap-up check and a thank-you for helping research.

Still have questions?
Our team is happy to talk it through. Call 1300 742 326.
Frequently asked questions
A clinical trial is a research study involving volunteers that helps researchers evaluate new treatments, medications, medical devices or approaches to healthcare. Clinical trials help determine whether these interventions are safe, effective and appropriate for wider use.
Clinical trials help advance healthcare by showing how treatments work, identifying possible side effects and exploring new ways to prevent, diagnose and manage medical conditions. By taking part, volunteers contribute to knowledge that may benefit people in the future.
Each trial has its own eligibility criteria, which may relate to your age, medical history, health conditions or current medications. Some studies are for people with a specific condition, while others involve healthy volunteers. Our research team can help you understand whether a study may be suitable.
Participant safety and wellbeing are central to clinical research. In Australia, trials must meet strict ethical and regulatory requirements and are reviewed by a Human Research Ethics Committee (HREC). Participants are monitored throughout the study.
All clinical trials involve some uncertainty and level of risk. Before you decide, the research team will explain the known and potential risks, possible benefits and available alternatives.
